Literature DB >> 24378232

Two novel RAD21 mutations in patients with mild Cornelia de Lange syndrome-like presentation and report of the first familial case.

Agata Minor1, Marwan Shinawi2, Jacob S Hogue3, Marisa Vineyard2, Damara R Hamlin3, Christopher Tan1, Kirsten Donato1, Latrice Wysinger1, Shaun Botes1, Soma Das1, Daniela Del Gaudio4.   

Abstract

Cornelia de Lange syndrome (CdLS) is a developmental disorder characterized by limb reduction defects, characteristic facial features and impaired cognitive development. Mutations in the NIPBL gene predominate; however, mutations in other cohesin complex genes have also been implicated, particularly in atypical and mild CdLS cases. Missense mutations and whole gene deletions in RAD21 have been identified in children with growth retardation, minor skeletal anomalies and facial features that overlap findings in individuals with CdLS. We report the first intragenic deletion and frameshift mutations identified in RAD21 in two patients presenting with atypical CdLS. One patient had an in-frame deletion of exon 13, while the second patient had a c.592_593dup frameshift mutation. The first patient presented with developmental delay, hypospadias, inguinal hernia and dysmorphic features while, the second patient presented with developmental delay, characteristic facial features, hirsutism, and hand and feet anomalies, with the first patient being milder than the second. The in-frame deletion mutation was found to be inherited from the mother who had a history of melanoma and other unspecified medical problems. This study expands the spectrum of RAD21 mutations and emphasizes the clinical utility of performing RAD21 mutation analysis in patients presenting with atypical forms of CdLS. Moreover, the variability of clinical presentation within families and low penetrance of mutations as well as the significance of performing molecular genetic testing in mildly affected patients are discussed. Published by Elsevier B.V.

Entities:  

Keywords:  CdLS; Cornelia de Lange Syndrome; Cornelia de Lange syndrome; Exonic copy number variants; Frameshift mutation; Germline mutation; OFC; RAD21; comparative threshold cycle method; ddCt; occipitofrontal circumference

Mesh:

Substances:

Year:  2013        PMID: 24378232     DOI: 10.1016/j.gene.2013.12.045

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  14 in total

Review 1.  Cohesin subunit RAD21: From biology to disease.

Authors:  Haizi Cheng; Nenggang Zhang; Debananda Pati
Journal:  Gene       Date:  2020-07-17       Impact factor: 3.688

2.  Mutations in RAD21 disrupt regulation of APOB in patients with chronic intestinal pseudo-obstruction.

Authors:  Elena Bonora; Francesca Bianco; Lina Cordeddu; Michael Bamshad; Ludmila Francescatto; Dustin Dowless; Vincenzo Stanghellini; Rosanna F Cogliandro; Greger Lindberg; Zeynel Mungan; Kivanc Cefle; Tayfun Ozcelik; Sukru Palanduz; Sukru Ozturk; Asuman Gedikbasi; Alessandra Gori; Tommaso Pippucci; Claudio Graziano; Umberto Volta; Giacomo Caio; Giovanni Barbara; Mauro D'Amato; Marco Seri; Nicholas Katsanis; Giovanni Romeo; Roberto De Giorgio
Journal:  Gastroenterology       Date:  2015-01-06       Impact factor: 22.682

3.  A Behavioural Assessment of Social Anxiety and Social Motivation in Fragile X, Cornelia de Lange and Rubinstein-Taybi Syndromes.

Authors:  Hayley Crawford; Joanna Moss; Laura Groves; Robyn Dowlen; Lisa Nelson; Donna Reid; Chris Oliver
Journal:  J Autism Dev Disord       Date:  2020-01

4.  [NIPBL gene mutations in two children with Cornelia de Lange syndrome].

Authors:  Yun-Jing Zhao; Hong-Wei Ma
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-05

5.  An experimental study of executive function and social impairment in Cornelia de Lange syndrome.

Authors:  Lisa Nelson; Hayley Crawford; Donna Reid; Joanna Moss; Chris Oliver
Journal:  J Neurodev Disord       Date:  2017-09-11       Impact factor: 4.025

6.  Clinical utility gene card for: Cornelia de Lange syndrome.

Authors:  Feliciano J Ramos; Beatriz Puisac; Carolina Baquero-Montoya; Ma Concepción Gil-Rodríguez; Inés Bueno; Matthew A Deardorff; Raoul C Hennekam; Frank J Kaiser; Ian D Krantz; Antonio Musio; Angelo Selicorni; David R FitzPatrick; Juan Pié
Journal:  Eur J Hum Genet       Date:  2014-12-24       Impact factor: 4.246

7.  Biochemical and structural characterization of HDAC8 mutants associated with Cornelia de Lange syndrome spectrum disorders.

Authors:  Christophe Decroos; Nicolas H Christianson; Laura E Gullett; Christine M Bowman; Karen E Christianson; Matthew A Deardorff; David W Christianson
Journal:  Biochemistry       Date:  2015-10-14       Impact factor: 3.162

8.  Cohesin complex-associated holoprosencephaly.

Authors:  Paul Kruszka; Seth I Berger; Valentina Casa; Mike R Dekker; Jenna Gaesser; Karin Weiss; Ariel F Martinez; David R Murdock; Raymond J Louie; Eloise J Prijoles; Angie W Lichty; Oebele F Brouwer; Evelien Zonneveld-Huijssoon; Mark J Stephan; Jacob Hogue; Ping Hu; Momoko Tanima-Nagai; Joshua L Everson; Chitra Prasad; Anna Cereda; Maria Iascone; Allison Schreiber; Vickie Zurcher; Nicole Corsten-Janssen; Luis Escobar; Nancy J Clegg; Mauricio R Delgado; Omkar Hajirnis; Meena Balasubramanian; Hülya Kayserili; Matthew Deardorff; Raymond A Poot; Kerstin S Wendt; Robert J Lipinski; Maximilian Muenke
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

9.  Face scanning and spontaneous emotion preference in Cornelia de Lange syndrome and Rubinstein-Taybi syndrome.

Authors:  Hayley Crawford; Joanna Moss; Joseph P McCleery; Giles M Anderson; Chris Oliver
Journal:  J Neurodev Disord       Date:  2015-07-30       Impact factor: 4.025

10.  Elucidating the genetic architecture of reproductive ageing in the Japanese population.

Authors:  Momoko Horikoshi; Felix R Day; Masato Akiyama; Makoto Hirata; Yoichiro Kamatani; Koichi Matsuda; Kazuyoshi Ishigaki; Masahiro Kanai; Hollis Wright; Carlos A Toro; Sergio R Ojeda; Alejandro Lomniczi; Michiaki Kubo; Ken K Ong; John R B Perry
Journal:  Nat Commun       Date:  2018-05-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.